Second-generation biopharmaceuticals.

Second-generation biopharmaceuticals.

Item
http://www.wikidata.org/entity/Q30342525
Glycosylation of therapeutic proteins: an effective strategy to optimize efficacyBiosimilar medicines - their use in the treatment of inflammatory bowel diseases. Position statement of the Working Group of the Polish National Consultant in GastroenterologySite-specific protein modifications through pyrroline-carboxy-lysine residuesStability and biological activity evaluations of PEGylated human basic fibroblast growth factor.Novel delivery systems for interferons.Detection and characterization of altered conformations of protein pharmaceuticals using complementary mass spectrometry-based approaches.Photosensitiser-antibody conjugates for photodynamic therapy.The importance of interfaces in protein drug delivery - why is protein adsorption of interest in pharmaceutical formulations?Conformational changes in oxidatively stressed monoclonal antibodies studied by hydrogen exchange mass spectrometrySensitive spectroscopic detection of large and denatured protein aggregates in solution by use of the fluorescent dye Nile red.Stakeholders' attitude to genetically modified foods and medicine.
P2860

Second-generation biopharmaceuticals.

Item
http://www.wikidata.org/entity/Q30342525
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Second-generation biopharmaceuticals.
@ast
Second-generation biopharmaceuticals.
@en
type
label
Second-generation biopharmaceuticals.
@ast
Second-generation biopharmaceuticals.
@en
prefLabel
Second-generation biopharmaceuticals.
@ast
Second-generation biopharmaceuticals.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Second-generation biopharmaceuticals.
@en
P2093
P304
P31
P356
10.1016/J.EJPB.2004.03.012
P407
P433
P478
P577
P698